These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38029830)

  • 1. TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer.
    Jiang T; Xia Y; Li Y; Lu C; Lin J; Shen Y; Lv J; Xie L; Gu C; Xu Z; Wang L
    Cancer Lett; 2024 Jan; 581():216510. PubMed ID: 38029830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tristetraprolin Overexpression in Gastric Cancer Cells Suppresses PD-L1 Expression and Inhibits Tumor Progression by Enhancing Antitumor Immunity.
    Guo J; Qu H; Shan T; Chen Y; Chen Y; Xia J
    Mol Cells; 2018 Jul; 41(7):653-664. PubMed ID: 29936792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 expression downregulation by RNF43 in gastric carcinoma enhances antitumour activity of T cells.
    Yang J; Wei M; Liu X; Shao X; Yan J; Liu J; Wen J; Zhang X; Dong R; Min M
    Scand J Immunol; 2023 Jun; 97(6):e13268. PubMed ID: 39007965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer.
    Ito S; Masuda T; Noda M; Hu Q; Shimizu D; Kuroda Y; Eguchi H; Tobo T; Utsunomiya T; Mimori K
    Oncology; 2020; 98(7):501-511. PubMed ID: 32380498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-methyladenosine reader protein IGF2BP1 suppresses CD8 + T cells-mediated tumor cytotoxicity and apoptosis in colon cancer.
    Peng Y; Zhang Z; Yang G; Dai Z; Cai X; Liu Z; Yun Q; Xu L
    Apoptosis; 2024 Apr; 29(3-4):331-343. PubMed ID: 37848671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAT4 overexpression promotes antitumor immunity by regulating the β-catenin/STT3/PD-L1 axis in cervical cancer.
    Wang D; Wu S; He J; Sun L; Zhu H; Zhang Y; Liu S; Duan X; Wang Y; Xu T
    J Exp Clin Cancer Res; 2023 Sep; 42(1):222. PubMed ID: 37658376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pumilio1 regulates NPM3/NPM1 axis to promote PD-L1-mediated immune escape in gastric cancer.
    Wang H; Zhou Z; Zhang J; Hao T; Wang P; Wu P; Su R; Yang H; Deng G; Chen S; Gu L; He Y; Zeng L; Zhang C; Yin S
    Cancer Lett; 2024 Jan; 581():216498. PubMed ID: 38029539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer.
    Guo Z; Zhou C; Zhou L; Wang Z; Zhu X; Mu X
    Cell Immunol; 2022 Feb; 372():104469. PubMed ID: 35114597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer.
    Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B
    Gene; 2021 Mar; 772():145376. PubMed ID: 33359128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N
    Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
    Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-derived extracellular vesicles containing microRNA-1290 promote immune escape of cancer cells through the Grhl2/ZEB1/PD-L1 axis in gastric cancer.
    Liang Y; Liu Y; Zhang Q; Zhang H; Du J
    Transl Res; 2021 May; 231():102-112. PubMed ID: 33321257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma.
    Yanagi T; Watanabe M; Hata H; Kitamura S; Imafuku K; Yanagi H; Homma A; Wang L; Takahashi H; Shimizu H; Hatakeyama S
    Cancer Res; 2018 Dec; 78(24):6795-6806. PubMed ID: 30389700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185.
    Qiu F; Xiong JP; Deng J; Xiang XJ
    Int J Clin Exp Pathol; 2015; 8(5):5053-61. PubMed ID: 26191199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1
    Saito R; Abe H; Kunita A; Yamashita H; Seto Y; Fukayama M
    Mod Pathol; 2017 Mar; 30(3):427-439. PubMed ID: 27934877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M
    Qiu X; Yang S; Wang S; Wu J; Zheng B; Wang K; Shen S; Jeong S; Li Z; Zhu Y; Wu T; Wu X; Wu R; Liu W; Wang HY; Chen L
    Cancer Res; 2021 Sep; 81(18):4778-4793. PubMed ID: 34301762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer.
    Zhang Y; Wang F; Sun HR; Huang YK; Gao JP; Huang H
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2209-2222. PubMed ID: 33891173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathway.
    Lv Y; Zhao Y; Wang X; Chen N; Mao F; Teng Y; Wang T; Peng L; Zhang J; Cheng P; Liu Y; Kong H; Chen W; Hao C; Han B; Ma Q; Zou Q; Chen J; Zhuang Y
    J Immunother Cancer; 2019 Feb; 7(1):54. PubMed ID: 30808413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBW7-mediated ubiquitination and destruction of PD-1 protein primes sensitivity to anti-PD-1 immunotherapy in non-small cell lung cancer.
    Liu J; Wei L; Hu N; Wang D; Ni J; Zhang S; Liu H; Lv T; Yin J; Ye M; Song Y
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36104103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis.
    Sun L; Huang C; Zhu M; Guo S; Gao Q; Wang Q; Chen B; Li R; Zhao Y; Wang M; Chen Z; Shen B; Zhu W
    Theranostics; 2020; 10(26):11950-11962. PubMed ID: 33204322
    [No Abstract]   [Full Text] [Related]  

  • 20. Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer.
    Kosaka Y; Inoue H; Ohmachi T; Yokoe T; Matsumoto T; Mimori K; Tanaka F; Watanabe M; Mori M
    Ann Surg Oncol; 2007 Sep; 14(9):2543-9. PubMed ID: 17597343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.